Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 175, Issue 5, Pages 2099-2110Publisher
ELSEVIER SCIENCE INC
DOI: 10.2353/ajpath.2009.090159
Keywords
-
Categories
Funding
- Alzheimer's Drug Discovery Foundation [290202]
- Basic Research Program of China [2007CB512200]
- University of California Discovery Grant Program
- Larry L. Hillblom Foundation
Ask authors/readers for more resources
Alzheimer's disease (AD) is pathologically characterized by accumulation of beta-amyloid (A beta) protein deposits and/or neurofibriffary tangles in association with progressive cognitive deficits. Although numerous studies have demonstrated a relationship between brain pathology and AD progression, the Alzheimer's pathological hallmarks have not been found in the AD retina. A recent report showed A beta plaques in the retinas of APPswe/PS1 Delta E9 transgenic mice. We now report the detection of A beta plaques with increased retinal microvascular deposition of A beta and neuroinflammation in Tg2576 mouse retinas. The majority of A beta-immunoreactive plaques were detected from the ganglion cell layer to the inner plexiform layer, and some plaques were observed in the outer nuclear layer, photoreceptor outer segment, and optic nerve. Hyperphosphorylated tau was labeled in the corresponding areas of the A beta plaques in adjacent sections. Although A beta vaccinations reduced retinal A beta deposits, there was a marked increase in retinal microvascular A beta deposition as well as local neuroinflammation manifested by microglial infiltration and astrogliosis linked with disruption of the retinal organization. These results provide evidence to support further investigation of the use of retinal imaging to diagnose AD and to monitor disease activity. (Am J Pathol 2009, 175:2099-2110; DOI: 10.2353/ajpath.2009.090159)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available